Immunizations Backup Technician
Adenovirus Vaccine - ANS Trade Name: Adenovirus Vaccine
Type: Live Virus
Route: Oral
Schedule: Single dose
Dose: 2 tablets (type 4 - white tablet, type 7- light peach tablet)
Booster: None
Licensing Age: 17-50 years of age
Anthrax Vaccine - ANS Trade Name: BioThrax
Type: Inactivated Bacteria
Route: IM
Schedule: Day 0, 4 weeks, 6, 12, and 18 months
Dose: 0.5ml
Booster: Annually
Licensing Age: 18-65 years of age
Hepatitis A Vaccine - ANS Trade Name: 1.) Havrix 2.) Vaqta
Type: Inactivated Virus
Route: IM
Schedule: Day 0 and 180
Dose: 1-18 years of age = 0.5ml; 19 years and older = 1.0ml
Booster: None
Licensing Age: 12 months and older
Hepatitis B Vaccine - ANS Trade Name: 1.) Engerix-B 2.) Recombivax
Type: Inactivated Virus
Route: IM
Schedule: Day 0, 30, 180
Dose: Birth-19 years of age = 0.5ml; 20 years and older = 1.0ml
Booster: None
Licensing Age: Birth and older
Human Papillomavirus Vaccine - ANS Trade Name: 1.) Gardasil 2.) Cervarix 3.) Gardasil 9
Type: Inactivated Virus
Route: IM
Schedule: Gardasil/Gardasil 9 = Day 0, 60, 180; Cervarix = Day 0, 30, 180
Dose: 0.5ml
Booster: None
Licensing Age: Gardasil = 9 - 26 years of age; Cervarix = 9 - 25 years of age; Gardasil 9 = Girls
9-26 years of age & Boys 9-15 years of age
, Influenza Vaccine (Injectable) - ANS Trade Name: 1.) Fluzone (high-dose; Intradermal) 2.)
Afluria 3.) Fluvirin 4.) Fluarix 5.) Agriflu
Type: Inactivated Virus
Route: IM
Schedule: Single dose
Dose: 0.5ml
Booster: Annually
Licensing Age: Fluzone is indicated for immunization in persons 6 months of age and older;
Fluzone Intradermal is indicated for persons aged 18 through 64 years; Fluzone High-Dose is
approved for use in persons 65 years of age and older; Afluria is licensed for immunization in
persons aged 5 years and older; however, the CDC's Advisory Committee on Immunization
Practices (ACIP) recommends that Afluria be used in persons aged 9 years and older because
of increased reports of febrile reactions noted in children 6 months through 8 years; Fluvirin is
indicated for persons aged 4 years and older; Fluarix is indicated for persons aged 3 years and
older; Agriflu is indicated for persons age 18 years and older.
Influenza Vaccine (Intranasal) - ANS Trade Name: Flumist
Type: Live Attenuated Virus
Route: IN
Schedule: Single dose
Dose: 0.2ml
Booster: Annually
Licensing Age: 2-49 years of age
Japanese Encephalitis Vaccine - ANS Trade Name: IXIARO
Type: Inactivated Virus
Route: IM
Schedule: Day 0 and 28
Dose: For children aged 2 months through 2 years, each dose is 0.25 mL, and for adults and
children aged ≥3 years, each dose is 0.5 m
Booster: ACIP recommends that if the primary series of JE-VC was administered >1 year
previously, a booster dose may be given before potential JE virus exposure
Licensing Age: 2 months of age and older
Measles Mumps and Rubella - ANS Trade Name: Measles, Mumps, Rubella
Type: Live Attenuated Virus
Route: SC
Schedule: Days 0 and 28
Dose: 0.5ml
Booster: N/A
Licensing Age: 12 months and older
Meningococcal Vaccine - ANS Trade Name: 1.) Menomune 2.) Menactra 3.) Menveo
Adenovirus Vaccine - ANS Trade Name: Adenovirus Vaccine
Type: Live Virus
Route: Oral
Schedule: Single dose
Dose: 2 tablets (type 4 - white tablet, type 7- light peach tablet)
Booster: None
Licensing Age: 17-50 years of age
Anthrax Vaccine - ANS Trade Name: BioThrax
Type: Inactivated Bacteria
Route: IM
Schedule: Day 0, 4 weeks, 6, 12, and 18 months
Dose: 0.5ml
Booster: Annually
Licensing Age: 18-65 years of age
Hepatitis A Vaccine - ANS Trade Name: 1.) Havrix 2.) Vaqta
Type: Inactivated Virus
Route: IM
Schedule: Day 0 and 180
Dose: 1-18 years of age = 0.5ml; 19 years and older = 1.0ml
Booster: None
Licensing Age: 12 months and older
Hepatitis B Vaccine - ANS Trade Name: 1.) Engerix-B 2.) Recombivax
Type: Inactivated Virus
Route: IM
Schedule: Day 0, 30, 180
Dose: Birth-19 years of age = 0.5ml; 20 years and older = 1.0ml
Booster: None
Licensing Age: Birth and older
Human Papillomavirus Vaccine - ANS Trade Name: 1.) Gardasil 2.) Cervarix 3.) Gardasil 9
Type: Inactivated Virus
Route: IM
Schedule: Gardasil/Gardasil 9 = Day 0, 60, 180; Cervarix = Day 0, 30, 180
Dose: 0.5ml
Booster: None
Licensing Age: Gardasil = 9 - 26 years of age; Cervarix = 9 - 25 years of age; Gardasil 9 = Girls
9-26 years of age & Boys 9-15 years of age
, Influenza Vaccine (Injectable) - ANS Trade Name: 1.) Fluzone (high-dose; Intradermal) 2.)
Afluria 3.) Fluvirin 4.) Fluarix 5.) Agriflu
Type: Inactivated Virus
Route: IM
Schedule: Single dose
Dose: 0.5ml
Booster: Annually
Licensing Age: Fluzone is indicated for immunization in persons 6 months of age and older;
Fluzone Intradermal is indicated for persons aged 18 through 64 years; Fluzone High-Dose is
approved for use in persons 65 years of age and older; Afluria is licensed for immunization in
persons aged 5 years and older; however, the CDC's Advisory Committee on Immunization
Practices (ACIP) recommends that Afluria be used in persons aged 9 years and older because
of increased reports of febrile reactions noted in children 6 months through 8 years; Fluvirin is
indicated for persons aged 4 years and older; Fluarix is indicated for persons aged 3 years and
older; Agriflu is indicated for persons age 18 years and older.
Influenza Vaccine (Intranasal) - ANS Trade Name: Flumist
Type: Live Attenuated Virus
Route: IN
Schedule: Single dose
Dose: 0.2ml
Booster: Annually
Licensing Age: 2-49 years of age
Japanese Encephalitis Vaccine - ANS Trade Name: IXIARO
Type: Inactivated Virus
Route: IM
Schedule: Day 0 and 28
Dose: For children aged 2 months through 2 years, each dose is 0.25 mL, and for adults and
children aged ≥3 years, each dose is 0.5 m
Booster: ACIP recommends that if the primary series of JE-VC was administered >1 year
previously, a booster dose may be given before potential JE virus exposure
Licensing Age: 2 months of age and older
Measles Mumps and Rubella - ANS Trade Name: Measles, Mumps, Rubella
Type: Live Attenuated Virus
Route: SC
Schedule: Days 0 and 28
Dose: 0.5ml
Booster: N/A
Licensing Age: 12 months and older
Meningococcal Vaccine - ANS Trade Name: 1.) Menomune 2.) Menactra 3.) Menveo
